Biomarin Pharmaceutical Inc. · NASDAQ:BMRN
Capital Research Global Investors's stake in Biomarin Pharmaceutical Inc. fell to 4.80% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 13, 2025
Capital Research Global Investors's stake in Biomarin Pharmaceutical Inc. fell to 4.80%, 9,150,655 shares, as a passive investor on Mar 31, 2025. Filed May 13, 2025 (Schedule 13G/A).
- Stake
- 4.80%
- Shares
- 9,150,655
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Capital Research Global Investors | 4.80% | 9,150,655 |
Source
Related
- Biomarin Pharmaceutical Inc.
- Capital Research Global Investors
- Biomarin Pharmaceutical Inc. shareholders
- Schedule 13G/A · Capital Research Global Investors · Feb 13, 2025
- Form 4 · Friberg Gregory R · Oct 1, 2026
- Form 4 · Plenge Robert M · Sep 14, 2026
- Form 4 · Davis George Eric · Sep 3, 2026
- Form 4 · Countouriotis Athena · Jun 4, 2026
- Form 4 · Walbert Timothy P · Jun 4, 2026